• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Biopharma Group - Articles and news items

How to get the best out of your high pressure homogeniser

How to get the best out of your high pressure homogeniser

Supplier news / 5 September 2016 / Biopharma Group

Fluid processing requirements are becoming ever more stringent, and so high pressure homogenisation is increasingly surfacing as a solution to meeting these needs…

How the implementation of Exalt™ for evaporative crystallisation studies improves stability and controlled delivery in drug development.

How the implementation of Exalt™ for evaporative crystallisation studies improves stability and controlled delivery in drug development.

Supplier news / 12 July 2016 / Biopharma Group

Polymorph screening is an important stage of drug development. The aim is to identify the different crystalline structures or polymorphs that a drug may appropriate…

How & why to build a QbD process to optimise the efficiency of your freeze drying projects

How & why to build a QbD process to optimise the efficiency of your freeze drying projects

Supplier news / 1 July 2016 / Biopharma Group

Quality by design (QbD) for lyophilisation is about building a robust process that proactively flags critical points and ensures consistent delivery of the best quality product, not only by minimising risk but also through greater understanding of the process itself…

How to avoid residual solvent when drying reverse phase HPLC fractions and prevent the formation of gums and oils.

How to avoid residual solvent when drying reverse phase HPLC fractions and prevent the formation of gums and oils.

Supplier news / 26 February 2016 / Biopharma Group

Traditional concentration of reverse phase HPLC fractions to dryness in a Genevac HT evaporator is a fast and safe process…

High Pressure Homogenisation & the next generation of drug delivery: Liposomes

High Pressure Homogenisation & the next generation of drug delivery: Liposomes

Supplier news / 24 February 2016 / Biopharma Group

Liposomes are valued delivery vehicles for potent and efficacious active pharmaceuticals…

Preserving Blood – Why We Need to Look at New Options

Preserving blood – why we need to look at new options

Supplier news / 22 February 2016 / Biopharma Group

Blood transfusions have been used successfully since the early 1900s, and blood banks have been in use since 1914…

How the Use of Placebos in Freeze-Drying Enables Cost Efficiencies in Process & Cycle Development

How the use of placebos in freeze-drying enables cost efficiencies in process & cycle development

Supplier news / 19 February 2016 / Biopharma Group

A placebo is a simulated or otherwise medically ineffectual treatment for a disease or other medical condition intended to make the recipient believe they are receiving something they are not in order to establish whether the true active agent has a noticeable remedy to the ailment it is intended to treat against the control…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +